Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case report.
Cancer Biol Ther
; 25(1): 2338644, 2024 Dec 31.
Article
in En
| MEDLINE
| ID: mdl-38650446
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylurea Compounds
/
Quinolines
/
Antineoplastic Combined Chemotherapy Protocols
/
Cholangiocarcinoma
/
Epstein-Barr Virus Infections
/
Antibodies, Monoclonal, Humanized
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Cancer Biol Ther
Journal subject:
NEOPLASIAS
/
TERAPEUTICA
Year:
2024
Document type:
Article
Affiliation country:
China
Country of publication:
Estados Unidos